Esperion Therapeutics Inc.. (ESPR) NASDAQ

$2.62 (0.08) (-2.96%)

Market Cap: $484.84M

As of 03/27/24 04:00 PM EDT. Market closed.

(ESPR)

Esperion Therapeutics Inc.. (ESPR)
NASDAQ

$2.62
(0.08) (-2.96%)

Market Cap: $484.84M

As of 03/27/24 04:00 PM EDT. Market closed.

Add to Portfolio

esperion therapeutics, inc. is a pharmaceutical company focused on developing and commercializing first-in-class, oral, ldl-c lowering therapies for the treatment of patients with hypercholesterolemia. etc-1002, the company's lead product candidate, is an inhibitor of atp citrate lyase, a well-characterized enzyme on the cholesterol biosynthesis pathway; the same pathway that includes hmg-coa ... read more

esperion therapeutics, inc. is a pharmaceutical company focused on developing and commercializing first-in-class, oral, ldl-c lowering therapies for the treatment of patients with hypercholesterolemia. etc-1002, the company's lead product candidate, is an inhibitor of atp citrate lyase, a well-characterized enzyme on the cholesterol biosynthesis pathway; the same pathway that includes hmg-coa reductase, the enzyme target of statins. the company has successfully completed its phase 1 and phase 2 development programs for etc-1002, and plans to initiate its etc-1002 phase 3 development program by the end of 2015. for more information, please visit www.esperion.com. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Timothy Mayleben
Full Time Employees
160
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$9.72M
URL
Address
3891 Ranchero Dr Ste 150, Michigan, Ann Arbor, 48108-2837.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Timothy Mayleben
Full Time Employees
160
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$9.72M
Address
3891 Ranchero Dr Ste 150, Michigan, Ann Arbor, 48108-2837.
PRICE CHART FOR ESPERION THERAPEUTICS INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$2.70
Days Range
$2.52 - $2.80
52 week range
$0.70 - $3.34
Volume
7,006,202
Avg. Volume (30 days)
5,223,398
Market Cap
$484.84M
Dividend Yield
-
P/E
(2.32)
Shares Outstanding
185,052,705
Open
-
Previous Close
$2.70
Days Range
$2.52 - $2.80
52 week range
$0.70 - $3.34
Volume
7,006,202
Avg. Volume (30 days)
5,223,398
Market Cap
$484.84M
Dividend Yield
-
P/E
(2.32)
Shares Outstanding
185,052,705
FINANCIAL STATEMENTS FOR ESPERION THERAPEUTICS INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ESPERION THERAPEUTICS INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Warren EricChief Commercial OfficerSep 20, 2023 Sale$1.2574292468,318Sep 21, 2023, 05:06 PM
Warren EricChief Commercial OfficerAug 18, 2023 Sale$1.4124334469,060Aug 21, 2023, 04:32 PM
Warren EricChief Commercial OfficerJul 19, 2023 Sale$1.5910616869,303Jul 20, 2023, 04:38 PM
Warren EricChief Commercial OfficerJun 21, 2023 Sale$1.4860389469,409Jun 22, 2023, 04:45 PM
Warren EricChief Commercial OfficerMay 17, 2023 Sale$1.6221935670,012May 18, 2023, 04:07 PM
CARROLL J MARTINDirectorMay 10, 2023 Buy$1.498,40912,54513,409May 11, 2023, 04:11 PM
CARROLL J MARTINDirectorMay 11, 2023 Buy$1.5723,09136,28536,500May 11, 2023, 04:11 PM
ROCAMBOLI STEPHENDirectorMay 10, 2023 Buy$1.508,11112,1268,111May 11, 2023, 04:10 PM
Koenig Sheldon L.President and CEOMay 09, 2023 Buy$1.2620,00025,192312,816May 10, 2023, 04:12 PM
Warren EricChief Commercial OfficerApr 19, 2023 Sale$1.2811514770,231Apr 20, 2023, 04:12 PM
Looker BenjaminGeneral CounselApr 19, 2023 Sale$1.271,2901,64183,663Apr 20, 2023, 04:12 PM
Foody Joanne M.Chief Medical OfficerApr 19, 2023 Sale$1.279381,192127,064Apr 20, 2023, 04:11 PM
Foody Joanne M.Chief Medical OfficerMar 17, 2023 Sale$1.783,8086,785128,002Mar 20, 2023, 04:19 PM
Koenig Sheldon L.President and CEOMar 17, 2023 Sale$1.786,99912,479292,816Mar 20, 2023, 04:16 PM
Warren EricChief Commercial OfficerMar 17, 2023 Sale$1.7852693770,346Mar 20, 2023, 04:16 PM
Warren EricChief Commercial OfficerMar 07, 2023 Sale$5.055,09025,73048,572Mar 08, 2023, 04:22 PM
Koenig Sheldon L.President and CEOMar 07, 2023 Sale$5.065,44127,510194,815Mar 08, 2023, 04:21 PM
Foody Joanne M.Chief Medical OfficerMar 07, 2023 Sale$5.073,88419,672103,060Mar 08, 2023, 04:20 PM
Looker BenjaminGeneral CounselJan 18, 2023 Sale$7.006,34744,40464,453Jan 19, 2023, 04:58 PM
Foody Joanne M.Chief Medical OfficerJan 18, 2023 Sale$6.991,1918,319106,944Jan 19, 2023, 04:58 PM
Foody Joanne M.Chief Medical OfficerOct 18, 2022 Sale$7.699427,242108,135Oct 19, 2022, 04:13 PM
Warren EricChief Commercial OfficerOct 18, 2022 Sale$7.6910782353,662Oct 19, 2022, 04:11 PM
Warren EricChief Commercial OfficerSep 19, 2022 Sale$6.922551,76553,769Sep 20, 2022, 04:09 PM
Koenig Sheldon L.President and CEOSep 19, 2022 Sale$6.943,39423,548198,257Sep 20, 2022, 04:08 PM
Warren EricChief Commercial OfficerAug 31, 2022 Buy$7.461,0007,46054,024Aug 31, 2022, 04:14 PM
Warren EricChief Commercial OfficerAug 17, 2022 Sale$6.821991,35653,024Aug 18, 2022, 04:10 PM
Koenig Sheldon L.President and CEOAug 05, 2022 Buy$5.808,60649,950198,771Aug 08, 2022, 04:14 PM
Foody Joanne M.Chief Medical OfficerJul 19, 2022 Sale$6.553,90125,552109,077Jul 20, 2022, 04:27 PM
Warren EricChief Commercial OfficerJul 19, 2022 Sale$6.584312,83753,223Jul 20, 2022, 04:27 PM
Koenig Sheldon L.President and CEOJun 17, 2022 Sale$4.994,55222,719190,165Jun 21, 2022, 04:07 PM
Warren EricChief Commercial OfficerJun 17, 2022 Sale$4.902561,25453,654Jun 21, 2022, 04:06 PM
CARROLL J MARTINDirectorJun 02, 2022 Buy$5.645,00028,1805,000Jun 03, 2022, 04:11 PM
Warren EricChief Commercial OfficerMay 17, 2022 Sale$5.981961,17253,910May 18, 2022, 04:30 PM
Koenig Sheldon L.President and CEOMar 17, 2022 Sale$4.585712,615194,717Mar 18, 2022, 04:29 PM
BIOTECH TARGET N V10% OwnerMay 24, 2021 Buy$20.22100,0002,021,6204,477,964May 26, 2021, 11:53 AM
BIOTECH TARGET N V10% OwnerMay 06, 2021 Buy$20.5780,0001,645,6324,177,964May 07, 2021, 03:23 PM
BIOTECH TARGET N V10% OwnerMay 05, 2021 Buy$20.02150,0003,002,8504,097,964May 07, 2021, 03:23 PM
MAYLEBEN TIMOTHY MPresident & CEODec 30, 2020 Option Exercise$2.1010,70022,427122,698Dec 31, 2020, 04:09 PM
BIOTECH TARGET N V10% OwnerNov 03, 2020 Buy$25.31200,0005,062,1203,947,964Nov 04, 2020, 04:37 PM
MAYLEBEN TIMOTHY MPresident & CEOMar 11, 2020 Buy$43.002,500107,500111,998Mar 12, 2020, 07:34 AM
MAYLEBEN TIMOTHY MPresident & CEOFeb 28, 2020 Buy$49.005,000245,000109,498Mar 02, 2020, 06:16 AM
BIOTECH TARGET N V10% OwnerJan 23, 2020 Buy$52.1220,0001,042,3983,747,964Jan 27, 2020, 12:51 PM
MAYLEBEN TIMOTHY MPresident & CEONov 06, 2019 Buy$36.985,000184,90083,663Nov 08, 2019, 04:14 PM
BIOTECH TARGET N V10% OwnerNov 06, 2019 Buy$37.3075,0002,797,5603,727,964Nov 08, 2019, 02:54 PM
MAYLEBEN TIMOTHY MPresident & CEOSep 04, 2019 Buy$34.205,000170,98276,163Sep 06, 2019, 04:22 PM
MAYLEBEN TIMOTHY MPresident & CEOSep 06, 2019 Buy$35.252,50088,12578,663Sep 06, 2019, 04:22 PM
BIOTECH TARGET N V10% OwnerSep 04, 2019 Buy$33.7880,0002,702,2083,652,964Sep 06, 2019, 04:09 PM
MAYLEBEN TIMOTHY MPresident & CEOAug 01, 2019 Buy$39.565,000197,80071,163Aug 02, 2019, 04:06 PM
BIOTECH TARGET N V10% OwnerJul 23, 2019 Buy$42.6550,0002,132,5653,572,964Jul 25, 2019, 12:42 PM
MAYLEBEN TIMOTHY MPresident & CEOJun 28, 2019 Buy$46.005,000230,00066,163Jul 01, 2019, 04:57 PM
Bartram RichardChief Financial OfficerApr 03, 2019 Sale$42.888,000343,04512,592Apr 05, 2019, 05:23 PM
MAYLEBEN TIMOTHY MPresident & CEOMar 29, 2019 Buy$40.005,000200,00061,163Apr 01, 2019, 04:41 PM
MAYLEBEN TIMOTHY MPresident & CEOMar 20, 2019 Buy$43.485,000217,40056,163Mar 21, 2019, 05:01 PM
VITULLO NICOLEDirectorMar 19, 2019 Sale$44.7315,329685,5961,700Mar 21, 2019, 09:02 AM
BIOTECH TARGET N V10% OwnerMar 14, 2019 Buy$49.8950,0002,494,3553,522,964Mar 15, 2019, 07:50 PM
MAYLEBEN TIMOTHY MPresident & CEOMar 14, 2019 Buy$48.735,000243,65051,163Mar 14, 2019, 04:57 PM
NEWTON ROGER SDirectorMar 12, 2019 Sale$50.0625,0001,251,500548,726Mar 14, 2019, 04:57 PM
BIOTECH TARGET N V10% OwnerJan 04, 2019 Buy$41.2980,0003,303,2563,472,964Jan 07, 2019, 05:10 PM
BIOTECH TARGET N V10% OwnerDec 24, 2018 Buy$39.9150,0001,995,7253,392,964Dec 26, 2018, 11:44 AM
BIOTECH TARGET N V10% OwnerDec 17, 2018 Buy$47.7360,0002,864,0703,342,964Dec 19, 2018, 01:14 PM
Boxer Capital, LLC10% OwnerNov 05, 2018 Sale$57.1660,0003,429,8431,134,750Nov 05, 2018, 07:56 PM
Boxer Capital, LLC10% OwnerNov 02, 2018 Sale$55.2140,0002,208,5001,198,750Nov 05, 2018, 07:56 PM
NEWTON ROGER SDirectorNov 02, 2018 Sale$50.7622711,523573,726Nov 02, 2018, 05:00 PM
NEWTON ROGER SDirectorNov 01, 2018 Sale$50.012,600130,026573,953Nov 02, 2018, 05:00 PM
NEWTON ROGER SDirectorOct 18, 2018 Sale$50.001005,000576,553Oct 18, 2018, 05:05 PM
NEWTON ROGER SDirectorOct 17, 2018 Sale$50.0212,673633,903576,653Oct 18, 2018, 05:05 PM
NEWTON ROGER SDirectorOct 16, 2018 Sale$50.019,400470,094589,326Oct 18, 2018, 05:05 PM
NEWTON ROGER SDirectorAug 27, 2018 Sale$51.0517,700903,610615,726Aug 29, 2018, 04:56 PM
NEWTON ROGER SDirectorAug 17, 2018 Sale$50.067,300365,438616,426Aug 22, 2018, 07:18 AM
BIOTECH TARGET N V10% OwnerAug 03, 2018 Buy$46.1450,0002,306,9703,282,964Aug 06, 2018, 03:23 PM
BIOTECH TARGET N V10% OwnerJul 12, 2018 Buy$41.7750,0002,088,3003,232,964Jul 13, 2018, 11:45 AM
BIOTECH TARGET N V10% OwnerJun 29, 2018 Buy$39.4850,0001,973,8053,182,964Jul 03, 2018, 11:55 AM
BIOTECH TARGET N V10% OwnerJun 21, 2018 Buy$38.5760,0002,314,2243,132,964Jun 25, 2018, 12:43 PM
BIOTECH TARGET N V10% OwnerJun 07, 2018 Buy$37.7960,0002,267,2923,072,964Jun 11, 2018, 02:59 PM
GOLDSTEIN DOV A MDDirectorJun 06, 2018 Option Exercise$16.4713,000214,10013,047Jun 08, 2018, 05:08 PM
BIOTECH TARGET N V10% OwnerJun 05, 2018 Buy$38.4760,0002,308,4403,012,964Jun 07, 2018, 02:34 PM
BIOTECH TARGET N V10% OwnerMay 18, 2018 Buy$42.2450,0002,112,0102,872,964May 22, 2018, 03:49 PM
BIOTECH TARGET N V10% OwnerMay 21, 2018 Buy$38.7780,0003,101,7602,952,964May 22, 2018, 03:49 PM
NEWTON ROGER SDirectorMar 29, 2018 Sale$72.3725,0001,809,277639,682Mar 29, 2018, 07:47 PM
NEWTON ROGER SDirectorFeb 07, 2018 Option Exercise$6.993,60825,220648,726Feb 09, 2018, 05:47 PM
NEWTON ROGER SDirectorFeb 07, 2018 Option Exercise$6.9934,651242,210652,334Feb 09, 2018, 05:47 PM
MAYLEBEN TIMOTHY MPresident & CEOJan 31, 2018 Option Exercise$1.174,5495,32546,163Feb 01, 2018, 05:29 PM
VITULLO NICOLEDirectorJan 24, 2018 Option Exercise$71.821178,40327,003Jan 26, 2018, 05:24 PM
VITULLO NICOLEDirectorJan 24, 2018 Option Exercise$71.826,814489,3811,101,080Jan 26, 2018, 05:24 PM
VITULLO NICOLEDirectorJan 24, 2018 Option Exercise$6.991,1938,33927,120Jan 26, 2018, 05:24 PM
VITULLO NICOLEDirectorJan 24, 2018 Option Exercise$6.9970,042489,5941,107,894Jan 26, 2018, 05:24 PM
VITULLO NICOLEDirectorJan 25, 2018 Sale$71.7911,674838,07615,329Jan 26, 2018, 05:24 PM
JANNEY DANIELDirectorJan 18, 2018 Option Exercise$74.966,640497,734624,564Jan 22, 2018, 08:49 PM
JANNEY DANIELDirectorJan 18, 2018 Option Exercise$6.9971,237497,947631,204Jan 22, 2018, 08:49 PM
Bartram RichardChief Financial OfficerJan 02, 2018 Option Exercise$3.7017,89266,20019,092Jan 03, 2018, 06:01 PM
GOLDSTEIN DOV A MDDirectorDec 18, 2017 Option Exercise$3.7021,47179,44321,518Dec 20, 2017, 05:53 PM
VITULLO NICOLEDirectorDec 06, 2017 Sale$53.859,326502,20525,927Dec 08, 2017, 04:14 PM
JANNEY DANIELDirectorMar 21, 2017 Sale$45.80350,00016,029,2631,588,627Mar 23, 2017, 04:45 PM
GOLDSTEIN DOV A MDDirectorMar 22, 2017 Sale$38.82312,64212,136,762837,125Mar 23, 2017, 04:37 PM
GOLDSTEIN DOV A MDDirectorMar 21, 2017 Sale$43.48487,35821,190,3261,149,767Mar 23, 2017, 04:37 PM
OMENN GILBERT SDirectorMar 21, 2017 Buy$42.261,00042,2601,000Mar 22, 2017, 08:02 AM
Lalwani Narendra D.Chief Operating OfficerNov 01, 2016 Buy$9.935,00049,6505,000Nov 03, 2016, 05:58 PM
MCGOVERN MARK EDirectorJul 06, 2016 Buy$10.004,40044,0005,000Jul 07, 2016, 07:17 AM
MCGOVERN MARK EDirectorJul 05, 2016 Buy$10.006006,000600Jul 07, 2016, 07:17 AM
MAYLEBEN TIMOTHY MPresident & CEOMay 04, 2016 Buy$14.857,000103,95041,614May 05, 2016, 07:33 AM
OMENN GILBERT SDirectorMar 01, 2016 Buy$15.285,00076,40010,000Mar 02, 2016, 07:23 AM
MAYLEBEN TIMOTHY MPresident & CEOJan 27, 2016 Buy$15.883,60057,16834,614Jan 28, 2016, 06:22 PM
MAYLEBEN TIMOTHY MPresident & CEOJan 15, 2016 Buy$14.087,200101,37631,014Jan 19, 2016, 07:16 AM
Aisling Capital II LP10% OwnerApr 24, 2015 Sale$106.2667,4697,169,3731,898,851Apr 27, 2015, 06:33 PM
Aisling Capital II LP10% OwnerApr 23, 2015 Sale$109.10150,00016,365,0001,904,594Apr 27, 2015, 06:33 PM
GOLDSTEIN DOV A MDDirectorApr 24, 2015 Sale$106.2667,4697,169,3731,898,851Apr 27, 2015, 06:32 PM
GOLDSTEIN DOV A MDDirectorApr 23, 2015 Sale$109.10150,00016,365,0001,904,594Apr 27, 2015, 06:32 PM
ENRIGHT PATRICK GDirectorMar 19, 2015 Sale$111.669,8251,097,09922,502Mar 23, 2015, 04:06 PM
ENRIGHT PATRICK GDirectorMar 19, 2015 Sale$111.66490,17554,734,4711,122,609Mar 23, 2015, 04:06 PM
Longitude Capital Partners, LLC10% OwnerNov 17, 2014 Sale$32.799,471310,53733,736Nov 19, 2014, 04:06 PM
Longitude Capital Partners, LLC10% OwnerNov 17, 2014 Sale$32.79472,55515,494,2851,683,178Nov 19, 2014, 04:06 PM
Longitude Capital Partners, LLC10% OwnerNov 18, 2014 Sale$31.611003,16128,194Nov 19, 2014, 04:06 PM
Longitude Capital Partners, LLC10% OwnerNov 18, 2014 Sale$31.615,004158,1841,406,622Nov 19, 2014, 04:06 PM
ENRIGHT PATRICK GDirectorNov 18, 2014 Sale$31.611003,16128,194Nov 19, 2014, 04:05 PM
ENRIGHT PATRICK GDirectorNov 18, 2014 Sale$31.615,004158,1841,406,622Nov 19, 2014, 04:05 PM
ENRIGHT PATRICK GDirectorNov 17, 2014 Sale$32.799,471310,53733,736Nov 19, 2014, 04:05 PM
ENRIGHT PATRICK GDirectorNov 17, 2014 Sale$32.79472,55515,494,2851,683,178Nov 19, 2014, 04:05 PM
Alta Partners VIII, L.P.10% OwnerOct 21, 2014 Buy$20.00500,00010,000,0002,552,189Oct 21, 2014, 07:33 PM
JANNEY DANIELDirectorOct 21, 2014 Buy$20.00500,00010,000,0002,552,189Oct 21, 2014, 06:53 PM
OMENN GILBERT SDirectorOct 21, 2014 Buy$20.005,000100,0005,000Oct 21, 2014, 05:31 PM
DOMAIN PARTERS VII L P10% OwnerOct 21, 2014 Buy$20.00500,00010,000,0002,566,935Oct 21, 2014, 12:15 PM
Longitude Capital Partners, LLC10% OwnerOct 09, 2014 Sale$30.001957037,757Oct 14, 2014, 06:54 AM
Longitude Capital Partners, LLC10% OwnerOct 09, 2014 Sale$30.0092427,7201,883,769Oct 14, 2014, 06:54 AM
ENRIGHT PATRICK GDirectorOct 09, 2014 Sale$30.001957037,757Oct 14, 2014, 06:51 AM
ENRIGHT PATRICK GDirectorOct 09, 2014 Sale$30.0092427,7201,883,769Oct 14, 2014, 06:51 AM
ENRIGHT PATRICK GDirectorOct 07, 2014 Sale$30.0411,692351,2301,884,693Oct 09, 2014, 04:03 PM
ENRIGHT PATRICK GDirectorOct 07, 2014 Sale$30.042357,05937,776Oct 09, 2014, 04:03 PM
Longitude Capital Partners, LLC10% OwnerOct 07, 2014 Sale$30.042357,05937,776Oct 09, 2014, 04:02 PM
Longitude Capital Partners, LLC10% OwnerOct 07, 2014 Sale$30.0411,692351,2301,884,693Oct 09, 2014, 04:02 PM
BLAIR JAMES C10% OwnerJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 05:03 PM
BLAIR JAMES C10% OwnerJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 05:03 PM
DP VII ASSOCIATES LP10% OwnerJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 05:00 PM
DOMAIN PARTERS VII L P10% OwnerJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 04:55 PM
Halak Brian K10% OwnerJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 04:51 PM
Halak Brian K10% OwnerJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 04:51 PM
DOVEY BRIAN H10% OwnerJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 04:48 PM
DOVEY BRIAN H10% OwnerJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 04:48 PM
SCHOEMAKER KATHLEEN K10% OwnerJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 04:40 PM
SCHOEMAKER KATHLEEN K10% OwnerJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 04:40 PM
TREU JESSE I10% OwnerJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 04:35 PM
TREU JESSE I10% OwnerJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 04:35 PM
VITULLO NICOLEDirectorJul 01, 2013 Buy$14.004,79167,07435,253Jul 02, 2013, 04:31 PM
VITULLO NICOLEDirectorJul 01, 2013 Buy$14.00280,9233,932,9222,066,935Jul 02, 2013, 04:31 PM
Longitude Capital Partners, LLC10% OwnerJul 01, 2013 Buy$14.004,25859,61238,011Jul 01, 2013, 04:40 PM
Longitude Capital Partners, LLC10% OwnerJul 01, 2013 Buy$14.00212,4182,973,8521,896,385Jul 01, 2013, 04:40 PM
MAYLEBEN TIMOTHY MPresident and CEOJul 01, 2013 Buy$14.005,00070,00028,814Jul 01, 2013, 04:39 PM
NEWTON ROGER SExecutive Chairman, CSOJul 01, 2013 Buy$14.0042,346592,844629,683Jul 01, 2013, 04:38 PM
LANGE LOUIS GDirectorJul 01, 2013 Buy$14.0010,714149,996197,703Jul 01, 2013, 04:38 PM
LANGE LOUIS GDirectorJul 01, 2013 Buy$14.003,50049,00017,814Jul 01, 2013, 04:38 PM
GOLDSTEIN DOV A MDDirectorJul 01, 2013 Buy$14.00238,1193,333,6662,054,594Jul 01, 2013, 04:37 PM
ENRIGHT PATRICK GDirectorJul 01, 2013 Buy$14.004,25859,61238,011Jul 01, 2013, 04:36 PM
ENRIGHT PATRICK GDirectorJul 01, 2013 Buy$14.00212,4182,973,8521,896,385Jul 01, 2013, 04:36 PM
JANNEY DANIELDirectorJul 01, 2013 Buy$14.00235,7143,299,9962,052,189Jul 01, 2013, 04:34 PM
Alta Partners VIII, L.P.10% OwnerJul 01, 2013 Buy$14.00235,7143,299,9962,052,189Jul 01, 2013, 04:33 PM
Aisling Capital II LP10% OwnerJul 01, 2013 Buy$14.00238,1193,333,6662,054,594Jul 01, 2013, 04:33 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Warren EricChief Commercial Officer09/20/2023924
Warren EricChief Commercial Officer08/18/2023344
Warren EricChief Commercial Officer07/19/2023168
Warren EricChief Commercial Officer06/21/2023894
Warren EricChief Commercial Officer05/17/2023356
CARROLL J MARTINDirector05/10/202312,545
CARROLL J MARTINDirector05/11/202336,285
ROCAMBOLI STEPHENDirector05/10/202312,126
Koenig Sheldon L.President and CEO05/09/202325,192
Warren EricChief Commercial Officer04/19/2023147
Looker BenjaminGeneral Counsel04/19/20231,641
Foody Joanne M.Chief Medical Officer04/19/20231,192
Foody Joanne M.Chief Medical Officer03/17/20236,785
Koenig Sheldon L.President and CEO03/17/202312,479
Warren EricChief Commercial Officer03/17/2023937
Warren EricChief Commercial Officer03/07/202325,730
Koenig Sheldon L.President and CEO03/07/202327,510
Foody Joanne M.Chief Medical Officer03/07/202319,672
Looker BenjaminGeneral Counsel01/18/202344,404
Foody Joanne M.Chief Medical Officer01/18/20238,319
Foody Joanne M.Chief Medical Officer10/18/20227,242
Warren EricChief Commercial Officer10/18/2022823
Warren EricChief Commercial Officer09/19/20221,765
Koenig Sheldon L.President and CEO09/19/202223,548
Warren EricChief Commercial Officer08/31/20227,460
Warren EricChief Commercial Officer08/17/20221,356
Koenig Sheldon L.President and CEO08/05/202249,950
Foody Joanne M.Chief Medical Officer07/19/202225,552
Warren EricChief Commercial Officer07/19/20222,837
Koenig Sheldon L.President and CEO06/17/202222,719
Warren EricChief Commercial Officer06/17/20221,254
CARROLL J MARTINDirector06/02/202228,180
Warren EricChief Commercial Officer05/17/20221,172
Koenig Sheldon L.President and CEO03/17/20222,615
BIOTECH TARGET N V10% Owner05/24/20212,021,620
BIOTECH TARGET N V10% Owner05/06/20211,645,632
BIOTECH TARGET N V10% Owner05/05/20213,002,850
MAYLEBEN TIMOTHY MPresident & CEO12/30/202022,427
BIOTECH TARGET N V10% Owner11/03/20205,062,120
MAYLEBEN TIMOTHY MPresident & CEO03/11/2020107,500
MAYLEBEN TIMOTHY MPresident & CEO02/28/2020245,000
BIOTECH TARGET N V10% Owner01/23/20201,042,398
MAYLEBEN TIMOTHY MPresident & CEO11/06/2019184,900
BIOTECH TARGET N V10% Owner11/06/20192,797,560
MAYLEBEN TIMOTHY MPresident & CEO09/04/2019170,982
MAYLEBEN TIMOTHY MPresident & CEO09/06/201988,125
BIOTECH TARGET N V10% Owner09/04/20192,702,208
MAYLEBEN TIMOTHY MPresident & CEO08/01/2019197,800
BIOTECH TARGET N V10% Owner07/23/20192,132,565
MAYLEBEN TIMOTHY MPresident & CEO06/28/2019230,000
Bartram RichardChief Financial Officer04/03/2019343,045
MAYLEBEN TIMOTHY MPresident & CEO03/29/2019200,000
MAYLEBEN TIMOTHY MPresident & CEO03/20/2019217,400
VITULLO NICOLEDirector03/19/2019685,596
BIOTECH TARGET N V10% Owner03/14/20192,494,355
MAYLEBEN TIMOTHY MPresident & CEO03/14/2019243,650
NEWTON ROGER SDirector03/12/20191,251,500
BIOTECH TARGET N V10% Owner01/04/20193,303,256
BIOTECH TARGET N V10% Owner12/24/20181,995,725
BIOTECH TARGET N V10% Owner12/17/20182,864,070
Boxer Capital, LLC10% Owner11/05/20183,429,843
Boxer Capital, LLC10% Owner11/02/20182,208,500
NEWTON ROGER SDirector11/02/201811,523
NEWTON ROGER SDirector11/01/2018130,026
NEWTON ROGER SDirector10/18/20185,000
NEWTON ROGER SDirector10/17/2018633,903
NEWTON ROGER SDirector10/16/2018470,094
NEWTON ROGER SDirector08/27/2018903,610
NEWTON ROGER SDirector08/17/2018365,438
BIOTECH TARGET N V10% Owner08/03/20182,306,970
BIOTECH TARGET N V10% Owner07/12/20182,088,300
BIOTECH TARGET N V10% Owner06/29/20181,973,805
BIOTECH TARGET N V10% Owner06/21/20182,314,224
BIOTECH TARGET N V10% Owner06/07/20182,267,292
GOLDSTEIN DOV A MDDirector06/06/2018214,100
BIOTECH TARGET N V10% Owner06/05/20182,308,440
BIOTECH TARGET N V10% Owner05/18/20182,112,010
BIOTECH TARGET N V10% Owner05/21/20183,101,760
NEWTON ROGER SDirector03/29/20181,809,277
NEWTON ROGER SDirector02/07/201825,220
NEWTON ROGER SDirector02/07/2018242,210
MAYLEBEN TIMOTHY MPresident & CEO01/31/20185,325
VITULLO NICOLEDirector01/24/20188,403
VITULLO NICOLEDirector01/24/2018489,381
VITULLO NICOLEDirector01/24/20188,339
VITULLO NICOLEDirector01/24/2018489,594
VITULLO NICOLEDirector01/25/2018838,076
JANNEY DANIELDirector01/18/2018497,734
JANNEY DANIELDirector01/18/2018497,947
Bartram RichardChief Financial Officer01/02/201866,200
GOLDSTEIN DOV A MDDirector12/18/201779,443
VITULLO NICOLEDirector12/06/2017502,205
JANNEY DANIELDirector03/21/201716,029,263
GOLDSTEIN DOV A MDDirector03/22/201712,136,762
GOLDSTEIN DOV A MDDirector03/21/201721,190,326
OMENN GILBERT SDirector03/21/201742,260
Lalwani Narendra D.Chief Operating Officer11/01/201649,650
MCGOVERN MARK EDirector07/06/201644,000
MCGOVERN MARK EDirector07/05/20166,000
MAYLEBEN TIMOTHY MPresident & CEO05/04/2016103,950
OMENN GILBERT SDirector03/01/201676,400
MAYLEBEN TIMOTHY MPresident & CEO01/27/201657,168
MAYLEBEN TIMOTHY MPresident & CEO01/15/2016101,376
Aisling Capital II LP10% Owner04/24/20157,169,373
Aisling Capital II LP10% Owner04/23/201516,365,000
GOLDSTEIN DOV A MDDirector04/24/20157,169,373
GOLDSTEIN DOV A MDDirector04/23/201516,365,000
ENRIGHT PATRICK GDirector03/19/20151,097,099
ENRIGHT PATRICK GDirector03/19/201554,734,471
Longitude Capital Partners, LLC10% Owner11/17/2014310,537
Longitude Capital Partners, LLC10% Owner11/17/201415,494,285
Longitude Capital Partners, LLC10% Owner11/18/20143,161
Longitude Capital Partners, LLC10% Owner11/18/2014158,184
ENRIGHT PATRICK GDirector11/18/20143,161
ENRIGHT PATRICK GDirector11/18/2014158,184
ENRIGHT PATRICK GDirector11/17/2014310,537
ENRIGHT PATRICK GDirector11/17/201415,494,285
Alta Partners VIII, L.P.10% Owner10/21/201410,000,000
JANNEY DANIELDirector10/21/201410,000,000
OMENN GILBERT SDirector10/21/2014100,000
DOMAIN PARTERS VII L P10% Owner10/21/201410,000,000
Longitude Capital Partners, LLC10% Owner10/09/2014570
Longitude Capital Partners, LLC10% Owner10/09/201427,720
ENRIGHT PATRICK GDirector10/09/2014570
ENRIGHT PATRICK GDirector10/09/201427,720
ENRIGHT PATRICK GDirector10/07/2014351,230
ENRIGHT PATRICK GDirector10/07/20147,059
Longitude Capital Partners, LLC10% Owner10/07/20147,059
Longitude Capital Partners, LLC10% Owner10/07/2014351,230
BLAIR JAMES C10% Owner07/01/201367,074
BLAIR JAMES C10% Owner07/01/20133,932,922
DP VII ASSOCIATES LP10% Owner07/01/201367,074
DOMAIN PARTERS VII L P10% Owner07/01/20133,932,922
Halak Brian K10% Owner07/01/201367,074
Halak Brian K10% Owner07/01/20133,932,922
DOVEY BRIAN H10% Owner07/01/201367,074
DOVEY BRIAN H10% Owner07/01/20133,932,922
SCHOEMAKER KATHLEEN K10% Owner07/01/201367,074
SCHOEMAKER KATHLEEN K10% Owner07/01/20133,932,922
TREU JESSE I10% Owner07/01/201367,074
TREU JESSE I10% Owner07/01/20133,932,922
VITULLO NICOLEDirector07/01/201367,074
VITULLO NICOLEDirector07/01/20133,932,922
Longitude Capital Partners, LLC10% Owner07/01/201359,612
Longitude Capital Partners, LLC10% Owner07/01/20132,973,852
MAYLEBEN TIMOTHY MPresident and CEO07/01/201370,000
NEWTON ROGER SExecutive Chairman, CSO07/01/2013592,844
LANGE LOUIS GDirector07/01/2013149,996
LANGE LOUIS GDirector07/01/201349,000
GOLDSTEIN DOV A MDDirector07/01/20133,333,666
ENRIGHT PATRICK GDirector07/01/201359,612
ENRIGHT PATRICK GDirector07/01/20132,973,852
JANNEY DANIELDirector07/01/20133,299,996
Alta Partners VIII, L.P.10% Owner07/01/20133,299,996
Aisling Capital II LP10% Owner07/01/20133,333,666
Load More Insider Transactions
FUNDS WITH A POSITION IN ESPERION THERAPEUTICS INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
PLATINUM INVESTMENT MANAGEMENT LTD2,810,5550.34%-11.88%Growth At A Reasonable Price, Value
BLACKROCK INC.2,112,8990.00016%7.37%Other
RENAISSANCE TECHNOLOGIES LLC1,420,1000.00657%588.85%Other
D. E. SHAW & CO., INC.1,213,2030.00317%NewOther
GEODE CAPITAL MANAGEMENT, LLC1,112,2460.00035%14.64%Other
UBS OCONNOR LLC527,1230.11%-16.59%Value
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP222,4820.02%No changeEvent Driven
AQR CAPITAL MANAGEMENT LLC202,9850.00041%ExitedOther
TUDOR INVESTMENT CORP ET AL72,5250.00071%ExitedEvent Driven, Other
BALYASNY ASSET MANAGEMENT L.P.37,1880.00021%NewEvent Driven
CHANGE IN SHARES OUTSTANDING FOR ESPERION THERAPEUTICS INC.
STOCK BUYBACKS FOR ESPERION THERAPEUTICS INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.57%
1Q
12/31/2023
06/30/2023
2.99%
2Q
12/31/2023
09/30/2022
65.92%
5Q
12/31/2023
06/30/2022
77.94%
6Q
12/31/2023
03/31/2022
84.57%
7Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.57%
1Q
06/30/2023
2.99%
2Q
09/30/2022
65.92%
5Q
06/30/2022
77.94%
6Q
03/31/2022
84.57%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ESPERION THERAPEUTICS INC.
LOADING...